Author: OurCrowd

OurCrowd’s portfolio company ReWalk featured in The Guardian

Jun 2, 2015 | ,

OurCrowd portfolio company ReWalk was featured in The Guardian, a leading British national daily newspaper. ReWalk is the developer of the FDA approved ReWalk exoskeleton device, providing paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits. The former army guardsman was defending a compound on his first tour of Afghanistan in 2012 when he was crushed by a collapsing wall. His injuries left him paralysed from the waist down and consigned him to a wheelchair. But today, Johnson is able to walk from his flat in Manchester’s Salford Quays down to the local newsagent for a paper, thanks to a ReWalk bionic suit. The remarkable exoskeleton device allows people with spinal cord injuries to stand upright and walk around. ReWalk raised $1,320,000 from OurCrowd investors in June 2013. Read more on The Guardian...

Read More
OurCrowd to reach $1B annually, 6 Israeli foodtech startups, & list of top influential Jewish innovators [OurCrowd Newsletter]

OurCrowd to reach $1B annually, 6 Israeli foodtech startups, & list of top influential Jewish innovators [OurCrowd Newsletter]

Jun 1, 2015 |

The latest from the Startup Nation: the list of biggest Jewish innovation influencers is out; 6 foodtech companies to sample; Visa won’t need a work visa when it opens an R&D center in Israel; and more… Start getting this weekly newsletter via email: Subscribe now OurCrowd CEO: We’ll reach raising $1B annually  Serial entrepreneur and investor, Jon Medved, is the man behind OurCrowd’s innovative investment model. This unconventional model has proven to be succeeding in raising impressive sums for Israeli startups, primarily for young companies. Since 2013, OurCrowd has invested a total of $120 million in 70 start-up companies in various fields. Medved believes that in 2015 alone, $120 million will be invested through OurCrowd, and his ambitious goal is to reach investments totaling $1 billion annually. Learn more. OurCrowd & Portfolio Companies in the News  Bizzabo featured in Times of Israel Jon Medved featured in The Jerusalem Post Jon Medved featured on Fox Business Ubimo featured in TechCrunch Boatbound featured in Washingtonian Webydo featured in CMS Critic A pinch of salt and a dash of innovation: 6 great foodtech startups from Israel What if that next big thing...

Read More
Conquering the Term Sheet: Everything you need to know about deal terms (Part 3)

Conquering the Term Sheet: Everything you need to know about deal terms (Part 3)

May 28, 2015 | , ,

Yesterday, we held the 3rd installment of OurCrowd’s 3-part educational series on how professional investors analyze and construct terms and conditions for their investments. On this week’s Q&A session, we continue to explore the fundamentals of deal terms in startup investing, discussing how to: Understand the basics of deal terms, from full ratchet to anti-dilution Get an insider’s view of crafting deal terms in startup investing Learn what to look for in a term sheet from seed stage to pre-IPO ::::::::::::::::::::::::::::::::: Missed the previous installments? View Part 1 and Part 2. ::::::::::::::::::::::::::::::::: To stay updated on future events and the best news from the Startup Nation, sign up for our newsletter, email us, and follow us on social media.   View the FULL program Download/view the presentation Conquering The Term Sheet Everything You Need To Know About Deal Terms Part 3 from OurCrowd LLC [xyz-ihs...

Read More